Korea lags in research spending

Published: 2007-08-29 06:59:00

Updated: 2007-08-29 06:59:00

Despite the government's plan to provide tax cut to research-oriented domestic pharmaceutical companies as part of follow-up measures to the free trade agreement (FTA) signed with the United States, experts suggest that the taxes levied on various R&D activities should be significantly reduced to...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK